Comparative effectiveness a common practice, group chief says

Comparative-effectiveness research involving drugs, medical devices and hospital services was a popular topic at the annual meeting of the Pharmaceutical Research and Manufacturers of America. The trade group expressed support for President Barack Obama's $1.1 billion plan to do this research. AstraZeneca CEO David Brennan, who was recently elected PhRMA's chairman, said such studies have become "a market requirement," with some companies adopting the practice to determine which medicines yield the most favorable patient outcomes.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations